Systematic review and meta-analysis of clinical trials examining the benefit of exercise programmes using Nordic Walking in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 2018; 56: 534–543.
Published: 6th February 2019
Authors: Golledge J, Maarij K, Moxon JV, Beard JD, Girold S, Wrang H et al.
There were five trials involving 294 patients. The addition of Nordic poles did not increase improvement in maximum walking distance over standard exercise programmes alone: standardized mean difference 1.31, 95 per cent confidence interval -1.28 to 3.91, P=0.322.Pubmed Link
You may also be interested in
Wearable sensor technology efficacy in peripheral vascular disease (wSTEP). A randomized controlled trial. Ann Surg 2018; 268: 1113-1118.
Authors: Normahani P, Kwasnicki R, Bicknell C, Allen L, Jenkins MP, Gibbs R et al.
A polymer-coated, paclitaxel eluting stent (Eluvia) versus a polymer-free, paclitaxel-coated stent (Zilver PTX) for endovascular femoropopliteal intervention (IMPERIAL): a randomized non-inferiority trial. Lancet 2018; 392: 1541-1551.
Authors: Gray WA, Keirse K, Soga Y, Benko A, Babaev A, Yokoi Y et al.
Systematic review and meta-analysis of high-pressure intermittent limb compression for the treatment of intermittent claudication. J Vasc Surg 2018; 67: 620–628.e2.
Authors: Oresanya L, Mazzei M, Bashir R, Farooqui A, Athappan G, Roth S et al.
A feasibility double-blind randomized placebo-controlled trial of extracorporeal shockwave therapy as a novel treatment for intermittent claudication. J Vasc Surg 2018; 67: 514–521.e2.
Authors: Harwood AE, Green J, Cayton T, Raza A, Wallace T, Carradice D et al.
Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease. The HONOR randomized clinical trial. JAMA 2018; 319: 1665-1676.
Authors: McDermott MM, Spring B, Berger S, Treat-Jacobson D, Conte MS, Creager MA et al.
Effect of granulocyte-macrophage colony-stimulating factor with or without supervised exercise on walking performance in patients with peripheral artery disease. The PROPEL randomized clinical trial. JAMA 2017; 318: 2089-2098.
Authors: McDermott MM, Ferrucci L, Tian L, Guralnik JM, Lloyd-Jones D, Kibbe MR et al.
A systematic review of treatment of intermittent claudication in the lower extremities. J Vasc Surg 2015; 61: Suppl 54S–73S.
Authors: Malgor RD, Alalahdab F, Elraiyah TA, Rizvi AZ, Lane M, Prokop LJ et al. et al.
Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization Or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014; 130: 939-947.
Authors: Nordanstig J, Taft C, Hensäter M, Perlander A, Osterberg K, Jivegård L et al.
The effect of supervision on walking distance in patients with intermittent claudication: a meta-analysis. Eur J Vasc Endovasc Surg 2014; 48: 169-184.
Authors: Gommans LNM, Saarloos R, Scheltinga MRM, Houterman S, de Bie RA, Fokkenrood HJP et al. et al.
A randomised controlled trial of supervised exercise regimens and their impact on walking performance, skeletal muscle mass and Calpain activity in patients with intermittent claudication. Eur J Vasc Endovasc Surg 2014; 47: 304-310.
Authors: Delaney CL, Miller MD, Chataway TK, Spark JI
Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 2013; 310: 57-65.
Authors: McDermott M, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L et al. et al.
A meta-analysis of the outcome of endovascular and non-invasive therapies in the treatment of intermittent claudication. J Vasc Surg 2011; 54: 1511-1521.
Authors: Ahimastos AA, Pappas EP, Buttner PG, Walker PJ, Kingwell BA, Golledge J et al.